ACHE and dementia: For dementia, among those who scored ≤18 on the MMSE, 9 of 27 (33%) were treated with acetylcholinesterase inhibitor rivastigminePrio4, 1 of 27 (4%) was treated with acetylcholinesterase inhibitor donepezilPrio4, and 10 of 27 (37%) were treated with memantinePrio9.